Inhibition of IAPP Aggregation and Toxicity by Natural Products and Derivatives

Fibrillar aggregates of human islet amyloid polypeptide, hIAPP, a pathological feature seen in some diabetes patients, are a likely causative agent for pancreatic beta-cell toxicity, leading to a transition from a state of insulin resistance to type II diabetes through the loss of insulin producing beta-cells by hIAPP induced toxicity. Because of the probable link between hIAPP and the development of type II diabetes, there has been strong interest in developing reagents to study the aggregation of hIAPP and possible therapeutics to block its toxic effects. Natural products are a class of compounds with interesting pharmacological properties against amyloids which have made them interesting targets to study hIAPP. Specifically, the ability of polyphenolic natural products, EGCG, curcumin, and resveratrol, to modulate the aggregation of hIAPP is discussed. Furthermore, we have outlined possible mechanistic discoveries of the interaction of these small molecules with the peptide and how they may mitigate toxicity associated with peptide aggregation. These abundantly found agents have been long used to combat diseases for many years and may serve as useful templates toward developing therapeutics against hIAPP aggregation and toxicity.

[1]  D. Milardi,et al.  Resveratrol interferes with the aggregation of membrane-bound human-IAPP: a molecular dynamics study. , 2015, European journal of medicinal chemistry.

[2]  J. Brender,et al.  Probing the sources of the apparent irreproducibility of amyloid formation: drastic changes in kinetics and a switch in mechanism due to micellelike oligomer formation at critical concentrations of IAPP. , 2015, The journal of physical chemistry. B.

[3]  A. Miranker,et al.  Peptide Amyloid Surface Display , 2014, Biochemistry.

[4]  S. Radford,et al.  Mutational Analysis of the Ability of Resveratrol To Inhibit Amyloid Formation by Islet Amyloid Polypeptide: Critical Evaluation of the Importance of Aromatic–Inhibitor and Histidine–Inhibitor Interactions , 2014, Biochemistry.

[5]  S. Radford,et al.  Screening and classifying small molecule inhibitors of amyloid formation using ion mobility spectrometry-mass spectrometry , 2014, Nature Chemistry.

[6]  A. Miranker,et al.  Fiber-dependent and -independent toxicity of islet amyloid polypeptide. , 2014, Biophysical journal.

[7]  W. V. Van Nostrand,et al.  Capping of Aβ42 Oligomers by Small Molecule Inhibitors , 2014, Biochemistry.

[8]  J. Brender,et al.  Interaction and reactivity of synthetic aminoisoflavones with metal-free and metal-associated amyloid-β , 2014 .

[9]  임미희 Synthetic Flavonoids, Aminoisoflavones: Interaction and Reactivity with Metal-Free and Metal-Associated Amyloid-b Species , 2014 .

[10]  A. Miranker,et al.  Small molecule screening in context: Lipid‐catalyzed amyloid formation , 2014, Protein science : a publication of the Protein Society.

[11]  D. Raleigh,et al.  General Amyloid Inhibitors? A Critical Examination of the Inhibition of IAPP Amyloid Formation by Inositol Stereoisomers , 2014, PloS one.

[12]  Suresh Govindaraghavan,et al.  Natural compounds and plant extracts as therapeutics against chronic inflammation in Alzheimer's disease--a translational perspective. , 2014, CNS & neurological disorders drug targets.

[13]  A. Miranker,et al.  Folded small molecule manipulation of islet amyloid polypeptide. , 2014, Chemistry & biology.

[14]  A. Ramamoorthy,et al.  Potent γ-secretase inhibitors/modulators interact with amyloid-β fibrils but do not inhibit fibrillation: a high-resolution NMR study. , 2014, Biochemical and biophysical research communications.

[15]  Huanxiang Liu,et al.  Exploring the Influence of EGCG on the β-Sheet-Rich Oligomers of Human Islet Amyloid Polypeptide (hIAPP1–37) and Identifying Its Possible Binding Sites from Molecular Dynamics Simulation , 2014, PloS one.

[16]  Jie Zheng,et al.  Non-selective ion channel activity of polymorphic human islet amyloid polypeptide (amylin) double channels. , 2014, Physical chemistry chemical physics : PCCP.

[17]  J. Fantini,et al.  Bexarotene blocks calcium-permeable ion channels formed by neurotoxic Alzheimer's β-amyloid peptides. , 2014, ACS chemical neuroscience.

[18]  Sanghyun Lee,et al.  Rational design of a structural framework with potential use to develop chemical reagents that target and modulate multiple facets of Alzheimer's disease. , 2014, Journal of the American Chemical Society.

[19]  S. Radford,et al.  Ion Mobility Spectrometry–Mass Spectrometry Defines the Oligomeric Intermediates in Amylin Amyloid Formation and the Mode of Action of Inhibitors , 2013, Journal of the American Chemical Society.

[20]  Ishita Guha Thakurta,et al.  Oxidative stress and amyloid beta toxicity in Alzheimer's disease: intervention in a complex relationship by antioxidants. , 2013, Current medicinal chemistry.

[21]  S. Radford,et al.  Aggregation modulators interfere with membrane interactions of β2-microglobulin fibrils. , 2013, Biophysical journal.

[22]  E. Karnaukhova,et al.  Copper(II)-human amylin complex protects pancreatic cells from amylin toxicity. , 2013, Physical chemistry chemical physics : PCCP.

[23]  M. Stefani,et al.  Protein Folding and Aggregation into Amyloid: The Interference by Natural Phenolic Compounds , 2013, International journal of molecular sciences.

[24]  J. Kelly,et al.  Toward the molecular mechanism(s) by which EGCG treatment remodels mature amyloid fibrils. , 2013, Journal of the American Chemical Society.

[25]  A. Miranker,et al.  A foldamer approach to targeting membrane bound helical states of islet amyloid polypeptide. , 2013, Chemical communications.

[26]  Hong Chen,et al.  Salvianolic acid B inhibits the amyloid formation of human islet amyloid polypeptideand protects pancreatic beta‐cells against cytotoxicity , 2013, Proteins.

[27]  A. Miranker,et al.  Common mechanism unites membrane poration by amyloid and antimicrobial peptides , 2013, Proceedings of the National Academy of Sciences.

[28]  N. Kotov,et al.  Resolution of oligomeric species during the aggregation of Aβ1-40 using (19)F NMR. , 2013, Biochemistry.

[29]  J. Brender,et al.  Insights into antiamyloidogenic properties of the green tea extract (−)-epigallocatechin-3-gallate toward metal-associated amyloid-β species , 2013, Proceedings of the National Academy of Sciences.

[30]  J. Brender,et al.  Cations as switches of amyloid-mediated membrane disruption mechanisms: calcium and IAPP. , 2013, Biophysical journal.

[31]  E. Wanker,et al.  Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases? , 2013, EPMA Journal.

[32]  S. Radford,et al.  Direct three-dimensional visualization of membrane disruption by amyloid fibrils , 2012, Proceedings of the National Academy of Sciences.

[33]  J. Brender,et al.  Alternative pathways of human islet amyloid polypeptide aggregation distinguished by (19)f nuclear magnetic resonance-detected kinetics of monomer consumption. , 2012, Biochemistry.

[34]  Ayyalusamy Ramamoorthy,et al.  Phosphatidylethanolamine enhances amyloid fiber-dependent membrane fragmentation. , 2012, Biochemistry.

[35]  Michael H. Hecht,et al.  A Novel Inhibitor of Amyloid β (Aβ) Peptide Aggregation , 2012, The Journal of Biological Chemistry.

[36]  J. Gaines,et al.  Kinetic profile of amyloid formation in the presence of an aromatic inhibitor by nuclear magnetic resonance. , 2012, ACS medicinal chemistry letters.

[37]  Maarten F. M. Engel,et al.  The polyphenol EGCG inhibits amyloid formation less efficiently at phospholipid interfaces than in bulk solution. , 2012, Journal of the American Chemical Society.

[38]  U. Fink,et al.  Structural properties of EGCG-induced, nontoxic Alzheimer's disease Aβ oligomers. , 2012, Journal of molecular biology.

[39]  Ayyalusamy Ramamoorthy,et al.  Two-step mechanism of membrane disruption by Aβ through membrane fragmentation and pore formation. , 2012, Biophysical journal.

[40]  D. Moffet,et al.  Myricetin Inhibits Islet Amyloid Polypeptide (IAPP) Aggregation and Rescues Living Mammalian Cells from IAPP Toxicity , 2012, The open biochemistry journal.

[41]  Samuel Sparks,et al.  Curcumin modulates the self-assembly of the islet amyloid polypeptide by disassembling α-helix. , 2012, Biochemical and biophysical research communications.

[42]  J. Brender,et al.  Site specific interaction of the polyphenol EGCG with the SEVI amyloid precursor peptide PAP(248-286). , 2012, The journal of physical chemistry. B.

[43]  D. Raleigh,et al.  Analysis of the inhibition and remodeling of islet amyloid polypeptide amyloid fibers by flavanols. , 2012, Biochemistry.

[44]  D. Raleigh,et al.  Morin hydrate inhibits amyloid formation by islet amyloid polypeptide and disaggregates amyloid fibers , 2012, Protein science : a publication of the Protein Society.

[45]  A. Naito,et al.  NMR characterization of monomeric and oligomeric conformations of human calcitonin and its interaction with EGCG. , 2012, Journal of molecular biology.

[46]  Shirley Y. Lee,et al.  A partially folded structure of amyloid-beta(1-40) in an aqueous environment. , 2011, Biochemical and biophysical research communications.

[47]  Per Westermark,et al.  Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. , 2011, Physiological reviews.

[48]  Hexafluoroisopropanol Induces Amyloid Fibrils of Islet Amyloid Polypeptide by Enhancing Both Hydrophobic and Electrostatic Interactions* , 2011, The Journal of Biological Chemistry.

[49]  J. Brender,et al.  The amyloidogenic SEVI precursor, PAP248-286, is highly unfolded in solution despite an underlying helical tendency. , 2011, Biochimica et biophysica acta.

[50]  Joan-Emma Shea,et al.  Resveratrol inhibits the formation of multiple-layered β-sheet oligomers of the human islet amyloid polypeptide segment 22-27. , 2011, Biophysical journal.

[51]  J. Brender,et al.  Biphasic effects of insulin on islet amyloid polypeptide membrane disruption. , 2011, Biophysical journal.

[52]  P. Magistretti,et al.  Aβ42 Neurotoxicity Is Mediated by Ongoing Nucleated Polymerization Process Rather than by Discrete Aβ42 Species* , 2010, The Journal of Biological Chemistry.

[53]  Yuguang Mu,et al.  The Molecular Basis of Distinct Aggregation Pathways of Islet Amyloid Polypeptide* , 2010, The Journal of Biological Chemistry.

[54]  M. Hecht,et al.  Small molecule microarrays enable the discovery of compounds that bind the Alzheimer's Aβ peptide and reduce its cytotoxicity. , 2010, Journal of the American Chemical Society.

[55]  Fanling Meng,et al.  The flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity. , 2010, Biochemistry.

[56]  H. Guy,et al.  Polyhistidine peptide inhibitor of the Abeta calcium channel potently blocks the Abeta-induced calcium response in cells. Theoretical modeling suggests a cooperative binding process. , 2010, Biochemistry.

[57]  J. Brender,et al.  Role of zinc in human islet amyloid polypeptide aggregation. , 2010, Journal of the American Chemical Society.

[58]  M. Biancalana,et al.  Molecular mechanism of Thioflavin-T binding to amyloid fibrils. , 2010, Biochimica et biophysica acta.

[59]  H. Guy,et al.  Polyhistidine Peptide Inhibitor of the Aβ Calcium Channel Potently Blocks the Aβ-Induced Calcium Response in Cells , 2010 .

[60]  J. Hofrichter,et al.  Evidence for a partially structured state of the amylin monomer. , 2009, Biophysical journal.

[61]  Tak W. Kee,et al.  The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds , 2009, The FEBS journal.

[62]  Roland Winter,et al.  Elucidating the mechanism of lipid membrane-induced IAPP fibrillogenesis and its inhibition by the red wine compound resveratrol: a synchrotron X-ray reflectivity study. , 2009, Journal of the American Chemical Society.

[63]  N. Opitz,et al.  Fluorescence microscopy studies on islet amyloid polypeptide fibrillation at heterogeneous and cellular membrane interfaces and its inhibition by resveratrol , 2009, FEBS letters.

[64]  J. Brender,et al.  Association of highly compact type II diabetes related islet amyloid polypeptide intermediate species at physiological temperature revealed by diffusion NMR spectroscopy. , 2009, Journal of the American Chemical Society.

[65]  Felipe Garcia Quiroz,et al.  Amyloid-β-Induced Ion Flux in Artificial Lipid Bilayers and Neuronal Cells: Resolving a Controversy , 2009, Neurotoxicity Research.

[66]  K. Jacobson,et al.  Small molecule blockers of the Alzheimer Aβ calcium channel potently protect neurons from Aβ cytotoxicity , 2009, Proceedings of the National Academy of Sciences.

[67]  Roland Winter,et al.  Inhibiting Islet Amyloid Polypeptide Fibril Formation by the Red Wine Compound Resveratrol , 2009, Chembiochem : a European journal of chemical biology.

[68]  Gerard J A Kroon,et al.  Amylin proprotein processing generates progressively more amyloidogenic peptides that initially sample the helical state. , 2008, Biochemistry.

[69]  Rebecca Deprez-Poulain,et al.  Natural Compounds: Leads or Ideas? Bioinspired Molecules for Drug Discovery , 2008, Chemical biology & drug design.

[70]  D. Ehrnhoefer,et al.  EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers , 2008, Nature Structural &Molecular Biology.

[71]  D. Raleigh,et al.  Rifampicin does not prevent amyloid fibril formation by human islet amyloid polypeptide but does inhibit fibril thioflavin-T interactions: implications for mechanistic studies of beta-cell death. , 2008, Biochemistry.

[72]  Maarten F. M. Engel,et al.  Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane , 2008, Proceedings of the National Academy of Sciences.

[73]  J. Brender,et al.  Membrane fragmentation by an amyloidogenic fragment of human Islet Amyloid Polypeptide detected by solid-state NMR spectroscopy of membrane nanotubes. , 2007, Biochimica et biophysica acta.

[74]  J. Díaz,et al.  Aβ ion channels. Prospects for treating Alzheimer's disease with Aβ channel blockers , 2007 .

[75]  N. Fullwood,et al.  Copper‐mediated formation of hydrogen peroxide from the amylin peptide: A novel mechanism for degeneration of islet cells in type‐2 diabetes mellitus? , 2007, FEBS letters.

[76]  Andrew D. Miranker,et al.  Direct detection of transient α‐helical states in islet amyloid polypeptide , 2007 .

[77]  R. Hepler,et al.  Solution State Characterization of Amyloid β-Derived Diffusible Ligands , 2006 .

[78]  Dong Jin Kim,et al.  A high-throughput screen for compounds that inhibit aggregation of the Alzheimer's peptide. , 2006, ACS chemical biology.

[79]  Ehud Gazit,et al.  Inhibition of Amyloid Fibril Formation by Polyphenols: Structural Similarity and Aromatic Interactions as a Common Inhibition Mechanism , 2006, Chemical biology & drug design.

[80]  H. Lashuel Membrane permeabilization: a common mechanism in protein-misfolding diseases. , 2005, Science of aging knowledge environment : SAGE KE.

[81]  Hai Lin,et al.  Amyloid ion channels: a common structural link for protein-misfolding disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[82]  A. Gee,et al.  Evidence for the Presence of Three Distinct Binding Sites for the Thioflavin T Class of Alzheimer's Disease PET Imaging Agents on β-Amyloid Peptide Fibrils* , 2005, Journal of Biological Chemistry.

[83]  E. Wilander,et al.  The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus , 1978, Diabetologia.

[84]  Kate A. Stafford,et al.  Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxicity by a small molecule. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[85]  U. Aebi,et al.  Atomic force microscopy reveals defects within mica supported lipid bilayers induced by the amyloidogenic human amylin peptide. , 2004, Journal of molecular biology.

[86]  V. Uversky,et al.  Conformational constraints for amyloid fibrillation: the importance of being unfolded. , 2004, Biochimica et biophysica acta.

[87]  E. Rhoades,et al.  Micelle formation by a fragment of human islet amyloid polypeptide. , 2003, Biophysical journal.

[88]  Y. Surh,et al.  Protective effect of resveratrol on β-amyloid-induced oxidative PC12 cell death ☆ , 2003 .

[89]  Y. Surh,et al.  Protective effect of resveratrol on beta-amyloid-induced oxidative PC12 cell death. , 2003, Free radical biology & medicine.

[90]  A. Miranker,et al.  Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis. , 2002, Biochemistry.

[91]  S. Woods,et al.  Amylin: a novel action in the brain to reduce body weight. , 2000, Endocrinology.

[92]  M. Delepierre,et al.  The “Pre-Molten Globule,” a New Intermediate in Protein Folding , 1997, Journal of protein chemistry.

[93]  B. Kagan,et al.  Pore Formation by the Cytotoxic Islet Amyloid Peptide Amylin (*) , 1996, The Journal of Biological Chemistry.

[94]  E. Kandel,et al.  Proceedings of the National Academy of Sciences of the United States of America. Annual subject and author indexes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[95]  R. Holman,et al.  Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. , 1988, Diabetes research.

[96]  C. Wernstedt,et al.  A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. , 1986, Biochemical and biophysical research communications.

[97]  J. Hutton The internal pH and membrane potential of the insulin-secretory granule. , 1982, The Biochemical journal.

[98]  E. Opie ON THE RELATION OF CHRONIC INTERSTITIAL PANCREATITIS TO THE ISLANDS OF LANGERHANS AND TO DIABETES MELUTUS , 1901, The Journal of experimental medicine.